Log in with your email address username.

×

Important notice

doctorportal Learning is on the move as we will be launching a new website very shortly. If you would like to sign up to dp Learning now to register for CPD learning or to use our CPD tracker, please email support@doctorportal.com.au so we can assist you. If you are already signed up to doctorportal Learning, your login will work in the new site so you can continue to enrol for learning, complete an online module, or access your CPD tracker report.

To access and/or sign up for other resources such as Jobs Board, Bookshop or InSight+, please go to www.mja.com.au, or click the relevant menu item and you will be redirected.

All other doctorportal services, such as Find A Doctor, are no longer available.

Testing times! Choosing Wisely when it comes to monitoring type 2 diabetes

- Featured Image

Harnessing the value of self-monitoring of blood glucose among people with non-insulin-treated type 2 diabetes

Affecting over one million Australians, type 2 diabetes (T2D) costs our country an unsustainable $15 billion annually,1 and is predicted to be the nation’s leading cause of disease burden by 2017.2 It is therefore essential to engage people with this condition in cost-effective therapy to reduce these costs, which arise mostly from treating the long-term complications (eg, blindness, stroke, amputation).

Self-monitoring of blood glucose levels (by means of a finger-prick blood sample analysed with an ambulatory blood glucose meter) is an essential part of managing type 1 diabetes and insulin-treated T2D; however, the clinical benefit for people with T2D who are not using insulin is, and we believe remains, a matter of debate.

The Government decides …

On 29 May 2015, the Australian federal government announced that access to testing strips for self-monitoring of blood glucose (SMBG) would be limited for most people with T2D. This announcement followed a much anticipated 2-year review process and extensive consultation. The Pharmaceutical Benefits Scheme (PBS) now stipulates that:

  • unrestricted access to SMBG strips will continue for people with T2D who are using insulin or other medicines (eg, corticosteroids,…

    email